New Zealand markets close in 3 hours 16 minutes

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
93.19-2.08 (-2.18%)
At close: 04:00PM EDT
87.53 -5.66 (-6.07%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.84B
Enterprise value 5.47B
Trailing P/E 41.60
Forward P/E 20.70
PEG ratio (5-yr expected) 1.73
Price/sales (ttm)3.74
Price/book (mrq)5.04
Enterprise value/revenue 4.18
Enterprise value/EBITDA 20.86

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 311.85%
S&P500 52-week change 329.31%
52-week high 397.97
52-week low 370.74
50-day moving average 386.80
200-day moving average 385.14

Share statistics

Avg vol (3-month) 3443.08k
Avg vol (10-day) 3424.66k
Shares outstanding 550.79M
Implied shares outstanding 651.92M
Float 850.43M
% held by insiders 10.71%
% held by institutions 1101.92%
Shares short (30 Apr 2024) 42.62M
Short ratio (30 Apr 2024) 45.98
Short % of float (30 Apr 2024) 47.86%
Short % of shares outstanding (30 Apr 2024) 45.16%
Shares short (prior month 28 Mar 2024) 42.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2024
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 8.98%
Operating margin (ttm)12.67%

Management effectiveness

Return on assets (ttm)5.96%
Return on equity (ttm)13.22%

Income statement

Revenue (ttm)1.31B
Revenue per share (ttm)25.82
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)N/A
EBITDA 294.1M
Net income avi to common (ttm)117.56M
Diluted EPS (ttm)2.24
Quarterly earnings growth (yoy)-30.70%

Balance sheet

Total cash (mrq)180.47M
Total cash per share (mrq)3.55
Total debt (mrq)873.88M
Total debt/equity (mrq)91.03%
Current ratio (mrq)2.56
Book value per share (mrq)18.90

Cash flow statement

Operating cash flow (ttm)181.75M
Levered free cash flow (ttm)118.16M